GTC Biotherapeutics (fka GTCB)

[exwannabe]

But doesn't fast-track generally imply priority review?

My understanding was that if a drug was fast-tracted it would generally recieve a priority review. Exceptions being if the NDA was for a different indication (than the basis of the fast track designation), or an improvement in SOC makes the drug a "me too".